The natural history of chronic hepatitis B virus infection (Q36388350)

13 August 2017

1 reference

title

The natural history of chronic hepatitis B virus infection. (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

Jean-Pierre Villeneuve

series ordinal

1

1 reference

13 August 2017

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

1 reference

13 August 2017

34 Suppl 1

1 reference

13 August 2017

S139-42

1 reference

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Natural history and prognostic factors for chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980024-1

7 January 2021

10.1016/S1386-6532(05)80024-1

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16461215